BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9820995)

  • 1. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
    Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
    Rouleau JL; de Champlain J; Klein M; Bichet D; Moyé L; Packer M; Dagenais GR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1993 Aug; 22(2):390-8. PubMed ID: 8101532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
    Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
    Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
    Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
    J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.
    Foy SG; Crozier IG; Richards AM; Nicholls MG; Turner JG; Frampton CM; Ikram H
    Eur Heart J; 1995 Jun; 16(6):770-8. PubMed ID: 7588920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of atrial natriuretic peptide in patients with myocardial infarction and mild left ventricular dysfunction.
    Bellone P; Derchi G; Tommasini G; Biorci ML; Randazzo M; Primarolo P; Vecchio C
    Int J Cardiol; 1993 Dec; 42(2):115-20. PubMed ID: 8112915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
    Tingberg E; Roijer A; Thilen U; Ohlin H
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):166-72. PubMed ID: 17086095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
    Vantrimpont P; Rouleau JL; Wun CC; Ciampi A; Klein M; Sussex B; Arnold JM; Moyé L; Pfeffer M
    J Am Coll Cardiol; 1997 Feb; 29(2):229-36. PubMed ID: 9014971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.
    Benedict CR; Johnstone DE; Weiner DH; Bourassa MG; Bittner V; Kay R; Kirlin P; Greenberg B; Kohn RM; Nicklas JM
    J Am Coll Cardiol; 1994 May; 23(6):1410-20. PubMed ID: 7909822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
    Hall C; Rouleau JL; Moyè L; de Champlain J; Bichet D; Klein M; Sussex B; Packer M; Rouleau J; Arnold MO
    Circulation; 1994 May; 89(5):1934-42. PubMed ID: 8181115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
    Sigurdsson A; Held P; Swedberg K; Wall B
    Eur Heart J; 1993 Aug; 14(8):1110-7. PubMed ID: 8404942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction.
    Omland T; Aarsland T; Aakvaag A; Lie RT; Dickstein K
    Am J Cardiol; 1993 Aug; 72(3):255-9. PubMed ID: 8342501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
    J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma renin activity in heart failure.
    Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
    Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.